Sheila Ranganath

3.4k total citations · 3 hit papers
25 papers, 2.7k citations indexed

About

Sheila Ranganath is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sheila Ranganath has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Sheila Ranganath's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers) and interferon and immune responses (6 papers). Sheila Ranganath is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers) and interferon and immune responses (6 papers). Sheila Ranganath collaborates with scholars based in United States, Switzerland and Germany. Sheila Ranganath's co-authors include Kenneth M. Murphy, Wenjun Ouyang, Theresa L. Murphy, William C. Sha, Deepta Bhattacharya, Max Löhning, Andreas Radbruch, Mario Assenmacher, Zhiguang Gao and David J. Farrar and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Sheila Ranganath

24 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of Th1 Development Mediated by GATA-3 through an IL-4-Independent Mechanism

1998 656 citations Wenjun Ouyang, Sheila Ranganath et al. Immunity profile →
Stat6-Independent GATA-3 Autoactivation Directs IL-4-Independent Th2 Development and Commitment

2000 576 citations Wenjun Ouyang, Max Löhning et al. Immunity profile →
Signaling and Transcription in T Helper Development

2000 533 citations Kenneth M. Murphy, Wenjun Ouyang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheila Ranganath United States	15	2.0k	728	586	325	208	25	2.7k
Ryoji Yagi United States	21	2.0k 1.0×	584 0.8×	346 0.6×	381 1.2×	138 0.7×	30	2.7k
Blair R. Renshaw United States	15	1.9k 1.0×	829 1.1×	446 0.8×	170 0.5×	182 0.9×	20	2.6k
Wei-ping Zheng United States	5	1.5k 0.7×	472 0.6×	331 0.6×	322 1.0×	149 0.7×	7	2.0k
Sachiko Suematsu Japan	18	1.6k 0.8×	782 1.1×	430 0.7×	147 0.5×	276 1.3×	31	2.6k
Shinsuke Taki Japan	28	2.7k 1.4×	800 1.1×	916 1.6×	236 0.7×	282 1.4×	64	3.5k
Naofumi Takemoto Japan	14	2.3k 1.1×	698 1.0×	767 1.3×	132 0.4×	172 0.8×	17	3.1k
Sophie M. Lehar United States	18	2.7k 1.4×	1.3k 1.8×	644 1.1×	260 0.8×	222 1.1×	22	3.9k
Ken‐ichiro Seino Japan	30	2.0k 1.0×	846 1.2×	809 1.4×	160 0.5×	140 0.7×	86	3.1k
Yasumichi Hitoshi Japan	22	1.1k 0.6×	814 1.1×	421 0.7×	242 0.7×	103 0.5×	48	2.1k
Jonathan M. Coquet Sweden	23	2.5k 1.2×	365 0.5×	531 0.9×	346 1.1×	105 0.5×	43	3.1k

Countries citing papers authored by Sheila Ranganath

Since Specialization

Citations

This map shows the geographic impact of Sheila Ranganath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Ranganath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Ranganath more than expected).

Fields of papers citing papers by Sheila Ranganath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Ranganath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Ranganath. The network helps show where Sheila Ranganath may publish in the future.

Co-authorship network of co-authors of Sheila Ranganath

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Ranganath. A scholar is included among the top collaborators of Sheila Ranganath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Ranganath. Sheila Ranganath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vara, Brandon, Samuel M. Levi, David A. Candito, et al.. (2021). Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Medicinal Chemistry Letters. 12(4). 653–661. 31 indexed citations

Xu, Jun, Nicolas Solban, Yun Wang, et al.. (2021). Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression (Adv. Therap. 10/2021). Advanced Therapeutics. 4(10). 1 indexed citations

Xu, Jun, Nicolas Solban, Yun Wang, et al.. (2021). Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression. Advanced Therapeutics. 4(10). 4 indexed citations

Singh, Latika, Eric S. Muise, Anannya Bhattacharya, et al.. (2020). ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells. Molecular Cancer Research. 19(4). 702–716. 51 indexed citations

Wang, Yun, Kelvin Zhang, Peter Georgiev, et al.. (2020). Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function. PLoS ONE. 15(12). e0243145–e0243145. 29 indexed citations

Scheuplein, Felix, Sheila Ranganath, Thomas J. McQuade, et al.. (2016). Abstract B30: Discovery and functional characterization of novel anti-PD-1 antibodies using ex vivo cell-based assays, single-cell immunoprofiling, and in vivo studies in humanized mice. Cancer Research. 76(15_Supplement). B30–B30. 3 indexed citations

Chen, Zhangguo, et al.. (2014). AID-Initiated DNA Lesions Are Differentially Processed in Distinct B Cell Populations. The Journal of Immunology. 193(11). 5545–5556. 12 indexed citations

Gostissa, Monica, et al.. (2009). Chromosomal location targets different MYC family gene members for oncogenic translocations. Proceedings of the National Academy of Sciences. 106(7). 2265–2270. 24 indexed citations

Bassing, Craig H., et al.. (2008). Vβ cluster sequences reduce the frequency of primary Vβ2 and Vβ14 rearrangements. European Journal of Immunology. 38(9). 2564–2572. 12 indexed citations

10.

Bassing, Craig H., et al.. (2008). H2ax/p53-deficient thymic lymphomas with clonal translocations Aberrant V(D)J recombination is not required for rapid development of.

11.

Bassing, Craig H., et al.. (2007). Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations. Blood. 111(4). 2163–2169. 14 indexed citations

12.

Wu, Çherry, et al.. (2007). Restriction of endogenous T cell antigen receptor β rearrangements to Vβ14 through selective recombination signal sequence modifications. Proceedings of the National Academy of Sciences. 104(10). 4002–4007. 14 indexed citations

13.

Basu, Uttiya, Jayanta Chaudhuri, Craig Alpert, et al.. (2005). The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature. 438(7067). 508–511. 207 indexed citations

14.

Hurov, Jonathan, Thaddeus S. Stappenbeck, Christian M. Zmasek, et al.. (2001). Immune System Dysfunction and Autoimmune Disease in Mice Lacking Emk (Par-1) Protein Kinase. Molecular and Cellular Biology. 21(9). 3206–3219. 74 indexed citations

15.

Ouyang, Wenjun, Max Löhning, Zhiguang Gao, et al.. (2000). Stat6-Independent GATA-3 Autoactivation Directs IL-4-Independent Th2 Development and Commitment. Immunity. 12(1). 27–37. 576 indexed citations breakdown →

16.

Murphy, Kenneth M., Wenjun Ouyang, Sheila Ranganath, & Theresa L. Murphy. (1999). Bi-stable Transcriptional Circuitry and GATA-3 Auto-activation in Th2 Commitment. Cold Spring Harbor Symposia on Quantitative Biology. 64(0). 585–588. 7 indexed citations

17.

Farrar, David J., Sheila Ranganath, & Kenneth M. Murphy. (1999). Molecular mechanisms in T helper phenotype development. Springer Seminars in Immunopathology. 21(3). 211–230. 3 indexed citations

18.

Ouyang, Wenjun, Sheila Ranganath, Deepta Bhattacharya, et al.. (1998). Inhibition of Th1 Development Mediated by GATA-3 through an IL-4-Independent Mechanism. Immunity. 9(5). 745–755. 656 indexed citations breakdown →

19.

Ranganath, Sheila, Wenjun Ouyang, William C. Sha, et al.. (1998). Cutting Edge: GATA-3-Dependent Enhancer Activity in IL-4 Gene Regulation. The Journal of Immunology. 161(8). 3822–3826. 155 indexed citations

20.

Ranganath, Sheila, Wenjun Ouyang, William C. Sha, et al.. (1998). GATA-3-dependent enhancer activity in IL-4 gene regulation.. PubMed. 161(8). 3822–6. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact